Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.2185 per EA under NDC 69238267501. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Dec 3, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238267501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209010FDA Approved
12/3/2018
TE Code
AB
On Market Since
12/3/2018
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 114 times since Jul 31, 2024, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2185 per EA |
|---|---|
| All-time high | $0.3380 (Nov 13, 2024) |
| All-time low | $0.2185 (Sep 23, 2026) |
| 52-week high | $0.2677 |
| 52-week low | $0.2185 |
| Median price | $0.2602 |
| Average price | $0.2724 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Olmesartan Medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $0.2185 per EA (NDC 69238267501), effective Sep 30, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 8.0%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Jul 31, 2024, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2185 (Sep 23, 2026) to a high of $0.3380 (Nov 13, 2024), with a median of $0.2602 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 69238267501) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.